Physician Assistant in Challis, ID Accepting Medicare
7 Physician Assistant nurses found. Showing 1 - 7
 Mr. Kenneth Henry Hyatt, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 1 Clinic Road, Challis, ID 83226 Phone: 208-879-4351 Fax: 208-879-5216 |
 Breeann Marie Petrie, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 431 E. Main St. #994, Challis, ID 83226 Phone: 208-833-1313 Fax: 833-839-1195 |
Mr. Matthew Chad Banks, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 611 Clinic Rd, Challis, ID 83226 Phone: 208-879-4351 Fax: 208-879-5216 |
Stephen Max Smith, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 611 Clinic Road, Challis, ID 83226 Phone: 208-879-4351 Fax: 208-879-5216 |
Thomas Daniel Fife, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 611 Clinic Rd, Challis, ID 83226 Phone: 208-879-4351 Fax: 208-879-5216 |
Miles Alan Haeberle, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 611 Clinic Rd, Challis, ID 83226 Phone: 208-879-4351 Fax: 208-879-5216 |
Joseph W Petrie, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 431 E. Main St., #994, Challis, ID 83226 Phone: 208-833-3773 Fax: 833-839-1175 |
News Archive
NanoBio awarded sixth U.S. patent covering its novel nanoemulsion technology
NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company's lead anti-infective and vaccine product candidates.
Pharmacy Care Alliance set to begin marketing to Medicare beneficiaries
The Pharmacy Care Alliance today announced that it received approval from Medicare to begin education, outreach and enrollment activities for its Medicare-approved drug discount card on May 3.
Researchers infuse antibody-studded iron nanoparticles into bloodstream to treat heart attack damage
Researchers at the Cedars-Sinai Heart Institute infused antibody-studded iron nanoparticles into the bloodstream to treat heart attack damage.
FDA acceptance of peginesatide NDA triggers $10M milestone payment to Affymax
Affymax, Inc. today announced that it has received a $10 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize peginesatide (formerly known as Hematide™), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.
Burnt-out employees have increased risk of heart disease, researcher finds
Americans work longer hours, take fewer vacation days, and retire later than employees in other industrialized countries around the globe.
› Verified 1 days ago